ArisGlobal Unveils NavaX Translation to Streamline Global Pharmacovigilance Processes
ArisGlobal Launches NavaX Translation for Global Pharmacovigilance
In a significant advancement for the pharmaceutical industry, ArisGlobal, a leading AI technology firm in Life Sciences, has introduced its innovative solution, NavaX Translation. This launch is aimed at eliminating manual translation efforts in global pharmacovigilance workflows.
The announcement was made during a pivotal partnership with TransPerfect Life Sciences, which allows ArisGlobal to integrate certified pharmaceutical translations directly into its LifeSphere Safety operations. As explained by Jason Bryant, Senior Vice President of AI Data Product Management at ArisGlobal, NavaX Translation embodies the company’s commitment to seamlessly integrate intelligent automation into core workflows.
The Need for NavaX Translation
Pharmacovigilance teams are increasingly inundated with safety reports submitted in diverse languages, each requiring thorough management involving multiple manual steps. Traditionally, this process entails exporting reports, coordinating with third-party translators, and then reintegrating those translations back into safety systems. Such a multi-step approach can lead to delays and errors, ultimately compromising the speed and quality of reporting.
How NavaX Translation Works
NavaX Translation brings a groundbreaking solution by employing advanced speech recognition technology and AI-driven translation processes. The system automatically detects non-English safety reports and forwards them directly for certified translations. These translations are executed using pharmaceutical-specific AI models alongside experienced linguists from TransPerfect, ensuring precision and compliance.
When translations are complete, they are sent back to LifeSphere Safety without the usual manual intervention, significantly reducing the time taken for translation management from hours to mere minutes.
Key Features of NavaX Translation
- - Automated Multilingual Capture with Instant Speech Recognition: The system instantly recognizes and processes non-English reports.
- - Certified Pharmaceutical Translations: Translations are crafted utilizing specialized models and skilled linguists, ensuring adherence to regulatory standards.
- - Seamless API Integration: Connects directly with LifeSphere Safety, eliminating the need for manual exports and imports.
- - Compliance-Driven Output: Outputs are compliant with global regulatory requirements, enhancing trust and reliability.
- - Scalable Operations: Designed to manage high volumes of cases across various markets efficiently.
The Impact on the Industry
According to ArisGlobal, the NavaX platform already processes over one million safety cases, with projections indicating this could rise to 2.5 million by mid-2026. Performance metrics have shown that NavaX offers over 95% data accuracy and efficiency improvements exceeding 30%, demonstrating a compelling return on investment.
Kevin Obarski, Chief Growth Officer of TransPerfect explains, “By collaborating with ArisGlobal, we incorporate validated translations into a truly intelligent safety platform. This collaboration empowers life sciences companies to scale confidently, swiftly, and with regulatory assurance.”
Availability
NavaX Translation will be available to LifeSphere Safety clients starting in July 2026. As the Life Sciences sphere continues evolving, innovative tools like NavaX Translation will be critical in optimizing workflows and enhancing patient safety.
To learn more about NavaX Translation and its capabilities, visit the official ArisGlobal website.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.